[19]
The applicant replies that
Bayer
is not authority for the proposition that as soon as the respondent files a "speck of evidence", the burden shifts to the applicant on the issue of validity in a NOC proceeding. Janssen contends that the evidence of the second person must demonstrate that the patent is invalid on a balance of probabilities before the statutory presumption is rebutted and no longer relevant.